TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 37 filers reported holding TRINITY BIOTECH PLC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $45,000 | -22.4% | 42,365 | +3.9% | 0.00% | – |
| Q4 2021 | $58,000 | -58.3% | 40,756 | -36.7% | 0.00% | – |
| Q3 2021 | $139,000 | -37.4% | 64,424 | +9.2% | 0.00% | – |
| Q1 2021 | $222,000 | -40.3% | 59,019 | -39.5% | 0.00% | – |
| Q4 2020 | $372,000 | +962.9% | 97,512 | +464.3% | 0.00% | – |
| Q3 2020 | $35,000 | -70.8% | 17,280 | -84.1% | 0.00% | – |
| Q1 2020 | $120,000 | -26.4% | 108,984 | -31.1% | 0.00% | – |
| Q4 2019 | $163,000 | -12.8% | 158,108 | +2.0% | 0.00% | – |
| Q3 2019 | $187,000 | -36.8% | 155,019 | -3.2% | 0.00% | – |
| Q2 2019 | $296,000 | -32.9% | 160,089 | +3.4% | 0.00% | -100.0% |
| Q1 2019 | $441,000 | +23.2% | 154,889 | -0.8% | 0.00% | 0.0% |
| Q4 2018 | $358,000 | -45.6% | 156,146 | -5.1% | 0.00% | 0.0% |
| Q3 2018 | $658,000 | -22.5% | 164,502 | -3.1% | 0.00% | 0.0% |
| Q2 2018 | $849,000 | -53.5% | 169,712 | -52.1% | 0.00% | -50.0% |
| Q1 2018 | $1,824,000 | -11.4% | 354,142 | -12.3% | 0.00% | -33.3% |
| Q4 2017 | $2,058,000 | +9.8% | 403,587 | +20.8% | 0.00% | 0.0% |
| Q3 2017 | $1,874,000 | -16.8% | 334,118 | -11.0% | 0.00% | -25.0% |
| Q2 2017 | $2,252,000 | -0.1% | 375,379 | -0.8% | 0.00% | 0.0% |
| Q1 2017 | $2,255,000 | -43.2% | 378,356 | -34.0% | 0.00% | -50.0% |
| Q4 2016 | $3,967,000 | -5.1% | 573,300 | +81.2% | 0.01% | +14.3% |
| Q3 2016 | $4,182,000 | +54.3% | 316,320 | +32.3% | 0.01% | +16.7% |
| Q2 2016 | $2,711,000 | +31.3% | 239,080 | +35.1% | 0.01% | +20.0% |
| Q1 2016 | $2,064,000 | -66.4% | 177,003 | -66.2% | 0.01% | -61.5% |
| Q4 2015 | $6,152,000 | +131.2% | 523,102 | +124.9% | 0.01% | +160.0% |
| Q3 2015 | $2,661,000 | +193.4% | 232,596 | +363.1% | 0.01% | +150.0% |
| Q2 2015 | $907,000 | -87.2% | 50,229 | -86.4% | 0.00% | -84.6% |
| Q1 2015 | $7,089,000 | +29.2% | 368,248 | +17.5% | 0.01% | +8.3% |
| Q4 2014 | $5,487,000 | +2148.8% | 313,365 | +2853.8% | 0.01% | +1100.0% |
| Q2 2014 | $244,000 | – | 10,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
| GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
| Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
| GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
| Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
| Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
| Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
| WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
| SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |